- Sweden is fourth European country to launch Sandoz’s award-winning new inhaler for patients with asthma and COPD
- Sandoz Sweden launches both 50-500 and 50-250 microgram dosage forms, following national marketing authorization earlier this year
- Airflusal Forspiro offers proven combination of salmeterol and fluticasone propionate in an innovative new device, co-developed with patients
Holzkirchen, June 23, 2014: Sandoz today announced the launch in Sweden of Airflusal® Forspiro®, an innovative new inhaler for patients with asthma and/or …